1-8 of 8
fares method
Close
Sort by
Journal Articles

Genomic Profiling of Mantle Cell Lymphoma Suggests Poor-Risk Profile Is Present at Diagnosis and Does Not Arise By Tumor Evolution

Erel Joffe, MDMSc, Anita Kumar, MD, Serena Zheng, Manik Uppal, Kurt S. Bantilan, MPH, Preston Atteberry, David J. Straus, MD, M. Lia Palomba, MD, Ariela Noy, MD, Steven M. Horwitz, MD, Alison J. Moskowitz, MD, Paul A. Hamlin, MD, Matthew J Matasar, MD, Connie Lee Batlevi, MD PhD, Gottfried R. von Keudell, MD PhD, Ahmet Dogan, MDPhD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 22.
https://doi.org/10.1182/blood-2019-129563
Published: 2019
Journal Articles

Optimized Culture Medium for Enhanced Ex Vivo expansion of Human Hematopoietic Stem Cells

Janet J Sei, PhD, Blake S Moses, PhD, Abigail Harris-Becker, MS, MinJung Kim, PhD, Navjot Kaur, PhD, Mohan C Vemuri, PhD, Curt I Civin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1965.
https://doi.org/10.1182/blood-2019-126174
Published: 2019
Journal Articles

Coordination of Pro- and Anti-Inflammatory Signals Determine Human Hematopoietic Stem and Progenitor Cell Expansion

Jalila Chagraoui, PhD, Elisa Tomellini, PhD, Leo Aubert, Iman Fares, PhD, Jean-Francois Spinella, PhD, Simon Girard, Nadine Mayotte, Philippe P Roux, PhD, Guy Sauvageau, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2555.
https://doi.org/10.1182/blood-2018-99-111917
Published: 2018
Journal Articles

EPCR: a novel marker of cultured cord blood HSCs

Gaëlle H. Martin, Christopher Y. Park
Journal: Blood
Blood (2017) 129 (25): 3279–3280.
https://doi.org/10.1182/blood-2017-05-780007
Published: 2017
Journal Articles

Post Transplant Brentuximab Maintenance Appears More Effective Than Post Transplant Salvage Brentuximab for Relapsed/Refractory Hogkin's Lymphoma

Amanda Chidiac, Radwan Massoud, MD, Mohamad Haidar, Elie Fares, Ali Bazarbachi, MD PhD, Jean El Cheikh, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5357.
https://doi.org/10.1182/blood.V128.22.5357.5357
Published: 2016
Journal Articles

Myeloma-Derived Exosomes and Soluble Factors Suppress Natural Killer Cell Function

Tarun K. Garg, PhD, Jessica I Gann, Priyangi A Malaviarachchi, BS, Kate Stone, BS, Veronica Macleod, Amy D Greenway, Nisreen S Akel, Ricky D Edmondson, PhD, Faith E Davies, MD, Joshua Epstein, DSc, Gareth J Morgan, MD PhD, Frits van Rhee, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2066.
https://doi.org/10.1182/blood.V128.22.2066.2066
Published: 2016
Journal Articles

Biomarkers Predict Graft-Vs-Host Disease Outcomes Better Than Clinical Response after One Week of Treatment

Hannah Major-Monfried, BA, Umut Ozbek, PhD, Anne S. Renteria, MD, Matthew J Hartwell, BA, Attaphol Pawarode, MD, Gregory A. Yanik, MD, Francis A Ayuk, MD, Ernst Holler, MD PhD, Yvonne A Efebera, MD MPH, William J Hogan, MD, Muna Qayed, MD MSc, Elizabeth O. Hexner, MD, Kitsada Wudhikarn, MD, Matthias Wolfl, MD, Rainer Ordemann, MD, Stephan Mielke, MD, Udomsak Bunworasate, MD, Steven M. Devine, MD, Nicolaus Kroeger, MD, Monzr Al-Malki, MD, Yi-Bin Chen, MD, Andrew C. Harris, MD, Madan H. Jagasia, MD, Carrie L Kitko, MD, Mark R Litzow, MD, Franco Locatelli, MD, Ryotaro Nakamura, MD, Pavan R. Reddy, MD, Ran Reshef, MD, Wolf Roesler, MD, Daniela Weber, MD, James Ferrara, MD DSc, John E. Levine, MD MS
Journal: Blood
Blood (2016) 128 (22): 510.
https://doi.org/10.1182/blood.V128.22.510.510
Published: 2016
Journal Articles

Molecular Indicators of High-Risk Disease.

John D. Shaughnessy, Jr., PhD, Bart Barlogie
Journal: Blood
Blood (2008) 112 (11): sci-6.
https://doi.org/10.1182/blood.V112.11.sci-6.sci-6
Published: 2008